Phase II trial of chemotherapy with 5-fl
โ
Abdelkrim Taamma; Abdelrahim Fandi; Nacer Azli; Pierre Wibault; Nadia Chouaki; A
๐
Article
๐
1999
๐
John Wiley and Sons
๐
English
โ 90 KB
๐ 2 views
## BACKGROUND. The aim of this study was to evaluate the toxicity and efficacy of the combination of 5-fluorouracil, bleomycin, epirubicin, and cisplatin (FBEC) in the treatment of patients with undifferentiated carcinoma of nasopharyngeal type (UCNT). The study included patients with metastatic or